Nature Reviews Cardiology 9,611 (2012).
doi:10.1038/nrcardio.2012.133
Author:Bryony M. Mearns
In patients with acute coronary syndrome (ACS) who have not undergone revascularization,but are receiving aspirin,prasugrel is associated with a similar rate of major cardiovascular events and has a similar safety profile as clopidogrel when used over the long term (∼15 months). These ‘neutral’












































